Related links
Enzalutamide-resistant castration resistant prostate cancer
by M Tucci · 2018 · Cited by 67 — Two new generation hormonal agents, abiraterone and enzalutamide, have shown an improvement in overall survival (OS) in both post- and ...
Learn more
FORM N-Q - SEC.gov
At May 31, 2013, Level 2 inputs were used in valuing the Fund's investments in each affiliated ... 8.50, 7-1-2026, 35,389, 38,245 ... TCM Sub LLC 144A.
Learn more